Perrigo Establishes Tax Base in $8.6B Elan Deal

July 29 (Bloomberg) -- Bloomberg News' Matthew Campbell reports that Perrigo Co. has come to an agreement to buy Irish drug company Elan Corp. for $8.6 billion, establishing a low-tax base for international expansion. He speaks on Bloomberg Television's "The Pulse."

Bloomberg ‹GO› Full Episode (02/05)
42:55 - Bloomberg ‹GO› hosted by Stephanie Ruhle and David Westin. Guests include SoftTech VC founder Jeff Clavier and Vanguard Chairman and CEO Bill McNabb. (Source: Bloomberg)
  • What Accelerated Nasdaq Stocks to Decline?
  • Did the Fed Miss Its Inflation Target?
  • How Are Bond Markets Reacting to the U.S. Jobs Report?